Related Experiment Videos
The first 500 patients with sacral anterior root stimulator implants: general description
1Spinal Injuries Unit, Royal National Orthopaedic Hospital, Stanmore, UK.
Paraplegia
|December 1, 1994
Summary
Sacral anterior root stimulators offer long-term bladder control solutions. A study of 500 patients found over 88% continued using the device for improved quality of life.
Area of Science:
- Urology
- Biomedical Engineering
- Neuromodulation
Background:
- Urinary incontinence significantly impacts quality of life.
- Sacral neuromodulation is an established treatment for bladder dysfunction.
- Sacral anterior root stimulators (SARS) offer a targeted approach to bladder control.
Purpose of the Study:
- To describe the outcomes of the first 500 patients receiving sacral anterior root stimulator implantation.
- To evaluate the long-term efficacy and usability of SARS for bladder control.
Main Methods:
- Retrospective analysis of the first 500 patients undergoing SARS implantation.
- Follow-up data collected over a period ranging from 3 months to 16.1 years.
- Assessment of device usage and patient-reported outcomes.
Main Results:
- 479 patients survived the implantation procedure.
- 424 out of 479 survivors (88.5%) were actively using their stimulators at the last follow-up.
- Mean follow-up duration was 4 years, with a maximum of 16.1 years.
Conclusions:
- Sacral anterior root stimulator implantation is a viable long-term solution for bladder control.
- High patient adherence and sustained device usage indicate significant therapeutic benefit.
- SARS technology demonstrates durable efficacy in managing complex bladder dysfunction.